• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
(R)-CR8

(R)-CR8

Product ID C6800
Cas No. 294646-77-8
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $104.10 Please Inquire
5 mg $312.20 Please Inquire
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

(R)-CR8 is an analog of roscovitine that inhibits cyclin-dependent kinases (CDKs) 1/2/3/5/7/9; it displays anticancer and neuroprotective activities. (R)-CR8 induces apoptosis and downregulates expression of Mcl-1 in neuroblastoma cells. In chromic myelogenous leukemia (CML) cells, (R)-CR8 inhibits cell cycle progression. In animal models of spinal cord injury, this compound decreases neurodegeneration, cognitive decline, and microglial activation. CR8 also decreases sensorimotor deficits, cognitive deficits, and lesion volume by limiting cell cycle activation in animal models of traumatic brain injury.

Product Info

Cas No.

294646-77-8

Purity

≥98%

Formula

C24H29N7O

Formula Wt.

431.54

Chemical Name

2-(R)-(1-Ethyl-2-hydroxyethylamino)-6-(4-(2-pyridyl)benzyl)-9-isopropylpurine

IUPAC Name

(2R)-2-[(9-Isopropyl-6-{[4-(2-pyridinyl)benzyl]amino}-9H-purin-2-yl)amino]-1-butanol

Solubility

Soluble in DMSO or 100% ethanol

Appearance

White to off-white solid

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

C6800 MSDS PDF

Info Sheet

C6800 Info Sheet PDF

References

Troadec S, Blairvacq M, Oumata N, et al. Antitumoral effects of cyclin-dependent kinases inhibitors CR8 and MR4 on chronic myeloid leukemia cell lines. J Biomed Sci. 2015 Jul 17;22:57. PMID: 26184865.

Wu J, Zhao Z, Sabirzhanov B, et al. Spinal cord injury causes brain inflammation associated with cognitive and affective changes: role of cell cycle pathways. J Neurosci. 2014 Aug 13;34(33):10989-1006. PMID: 25122899.

Kabadi SV, Stoica BA, Loane DJ, et al. CR8, a novel inhibitor of CDK, limits microglial activation, astrocytosis, neuronal loss, and neurologic dysfunction after experimental traumatic brain injury. J Cereb Blood Flow Metab. 2014 Mar;34(3):502-13. PMID: 24398934.

Bettayeb K, Baunbæk D, Delehouze C, et al. CDK Inhibitors Roscovitine and CR8 Trigger Mcl-1 Down-Regulation and Apoptotic Cell Death in Neuroblastoma Cells. Genes Cancer. 2010 Apr;1(4):369-80. PMID: 21779453.

Bettayeb K, Oumata N, Echalier A, et al. CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases. Oncogene. 2008 Oct 2;27(44):5797-807. PMID: 18574471.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • M7531

    γ-1 Melanocyte Stimulating Hormone

    Endogenous peptide hormone derived from POMC, invo...
    ≥98%
  • A4521

    Alfacalcidol

    Vitamin D analog.
    ≥98%
  • C2943

    Chlorogenic Acid (from Eucommia)

    Polyphenol derivative of caffeic acid found in Euc...
    ≥98%
  • P1869

    Perindopril Erbumine

    ACE inhibitor.
    ≥95%
  • C0156

    9-Nitro-20S-camptothecin

    Camptothecin derivative; topoisomerase I inhibitor...
    ≥98%
  • M1779

    Methyldopa Sesquihydrate

    DOPA decarboxylase inhibitor, indirect α2-adrener...
    ≥98%
  • F5968

    Foretinib

    ROS1, MET, Ron, Axl, TIE-2, VEGFR2 inhibitor.
    ≥98%
  • O1179

    n-Octyl-4-methylcaffeate

    Derivative of methyl caffeate, hydroxycinnamic aci...
    ≥98%
  • U6856

    Urocortin II, human

    Endogenous peptide, involved in stress signaling; ...
    ≥95%
  • A9714

    AZD-1152-HQPA

    AurKA/B inhibitor.
    ≥98%
  • K9858

    Kyotorphin

    Opioid neuropeptide; kyotorphin agonist.
    ≥95%
  • Z161025

    β-Zearalenol

    β-Zearalenol is a mycotoxin that has structural s...
    ≥98%
  • C2845

    Levo-Chloramphenicol

    Protein translation inhibitor, peptidyl transferas...
    ≥98%
  • T1678

    D,L-Tetrahydropalmatine

    Alkaloid found in Corydalis and Stephania; D1/2 an...
    ≥98%
  • T1020

    n-Butyl Analog of Paclitaxel

    n-Butyl Analog of Paclitaxel is an impurity of the...
    ≥95%
  • V0273

    Vasoactive Intestinal Peptide

    Endogenous peptide hormone, involved in enteric mo...
    ≥95%
  • L0254

    Lansoprazole

    H+/K+ ATPase inhibitor.
    ≥98%
  • C4000

    CK-636

    Arp2/3 inhibitor.
    ≥98%
  • B5609

    Boc-GRR-AMC

    Peptide, protease substrate.
    ≥98%
  • H8048

    Human Follicular Gonadotropin Releasing Peptide

    Peptide, stimulates release of LH and FSH.
    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only